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The classic view of brain and behavioral sexual differentiation holds that the neural mechanisms controlling sexual behavior in female
rodents develop in the absence of ovarian sex hormone actions. However, in a previous study, female aromatase knock-out (ArKO)mice,
which cannot convert testosterone to estradiol, showed deficientmale-oriented partner preference and lordosis behaviors in response to
adult ovarian hormones, raising the possibility that estradiolmay contribute to the development of these female sexual behaviors. In the
present experiments, administering estradiol prepubertally [between postnatal day 15 (P15) and P25] significantly enhanced the ability
of ArKO female mice to display lordosis behavior in response to ovarian hormones administered later in adulthood, whereas treatment
with estradiol over an earlier postnatal period (P5–P15) had no such effect. Treatment of ArKO females with estradiol between P15 and
P25 also rescued their later preference to approach distal cues from an intact male over an estrous female. ArKO females also displayed
significantly less female-directed (male-typical) mounting behavior than wild-type control females when treated with testosterone in
adulthood. Prepubertal estradiol treatment failed to reverse this deficit in ArKO females, whereas earlier postnatal estradiol augmented
latermounting in both genotypes. Our results provide new evidence for an organizing role of prepubertal estradiol in the development of
neural mechanisms that control female-typical sexual behavior.
Introduction
The classic view of brain sexual differentiation holds that the
mammalian female nervous system develops in the absence of
any active sex steroid signaling, whereas the male requires testos-
terone (T), secreted over a species-specific perinatal period, to
organize neural circuits that later control male-typical sexual be-
haviors. Furthermore, strong evidence suggests that many of the
organizational actions of T result from estradiol (E2) formed via
neural aromatization of T (Baum et al., 1990; De Vries and Si-
merly, 2002). However, a contribution of perinatal E2 to neural
differentiation in female mammals was first proposed by Toran-
Allerand (1976), who found that E2 promoted neurite outgrowth
from fetal hypothalamic explants of both sexes. Furthermore,
several studies (Lisk, 1969; Gerall et al., 1973; Do¨hler et al., 1984;
Baum and Tobet, 1986) suggested that perinatal E2 could con-
tribute to female brain and behavioral development. Eventually,
however, the hypothesis languished due to the absence of conclu-
sive supportive evidence. The creation of the aromatase knock-
out (ArKO) mouse, carrying a targeted mutation in the Cyp19
genewhich renders animals of both sexes unable to convert T into
E2 (Fisher et al., 1998; Honda et al., 1998), allowed us to reassess
the role of E2 in the development of the female brain. Female
ArKO mice, ovariectomized in adulthood and subsequently
treated with E2 and progesterone (P4), displayed less lordosis
behavior than wild-type (WT) females (Bakker et al., 2002). Fur-
thermore, ArKO females spent less time investigating volatile
body odors from conspecifics of either sex (Bakker et al., 2002).
These data suggest a potential role of E2 in female behavioral
differentiation. We recently identified an estrogen-sensitive pe-
riod during female development by using the expression of an
E2-dependent neural gene, the progestin receptor (PR) (Brock et
al., 2010). The amount of hypothalamic PR-immunoreactivity
was significantly lower in female ArKOmice than inWT females
at several prepubertal ages including postnatal day 15 (P15), P20,
and P25, but not at earlier postnatal ages (P0, P5, or P10). Thus E2
may contribute to female-typical sexual differentiation perhaps
beginning after P7when themouse ovary first produces E2 (Man-
nan and O’Shaughnessy, 1991).
We asked whether either early postnatal (P5–P15) (experi-
ment 1) or prepubertal (P15–P25) (experiment 2) treatmentwith
E2 would reverse later deficits in lordosis behavior and the inves-
tigation of potential sexual partners in ArKO females tested fol-
lowing adult treatment with E2 and P4. Female mice normally
display surprisingly high levels of male-like mounting behavior
toward other females around the time of estrus; they also show
high levels of mounting after adult ovariectomy and T treatment
(Edwards, 1971; Martel and Baum, 2009). We (Bakker et al.,
2002) previously observed reduced mounting in ArKO females,
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suggesting that E2 normallymasculinizes aspects of sexual behav-
ior in female mice. Therefore we also asked whether early post-
natal (experiment 1) or prepubertal (experiment 2) E2 treatment




ArKOmice were generated by targeted disruption of exons 1 and 2 of the
Cyp 19 gene (Honda et al., 1998). Heterozygousmales and females of the
CD1 strain were bred to generate WT and homozygous-null (ArKO)
offspring at theGIGA-Neurosciences,University of Lie`ge, Belgium. Food
(“phytoestrogen-free” mouse chow D10001 AIN-76A, Brogaarden) and
water were available to mice ad libitum. Pregnant females were checked
daily for parturition (P0) toward the end of pregnancy. All female sub-
jects were weaned at P35 and genotyped by PCR analysis of tail DNA.
All male and female stimulus mice were derived from a local CD1
breeding colony. Stimulus females were ovariectomized in adulthood
under general anesthesia and implanted with a 5-mm-long SILASTIC
capsule (inner diameter, 1.57 mm; outer diameter, 2.41 mm) containing
17-estradiol (formore details, see Bakker et al., 2002). Beginning several
weeks later, subjects were brought into behavioral estrus on several oc-
casions by added treatment with P4 (500 g/mouse) 3 h before each test
session.
All experiments were conducted in accordance with the guidelines set
forth by the National Institutes of Health “Guide for the Care and Use of
Laboratory Animals, Eighth Edition,” and were approved by the Ethical
Committee for Animal Use of the University of Liege.
Early postnatal and prepubertal hormonal treatments
A first cohort (experiment 1) of WT and ArKO females was injected
subcutaneously over the early postnatal ages of P5–P15 with either estra-
diol benzoate (EB) (0.5 g every 2 d) or sesame oil; additional groups of
WT and ArKO females were not injected during this period. The latter
group was included to control for any potential stress induced by re-
peated injections during early development. A second cohort (experi-
ment 2) of WT and ArKO females was injected subcutaneously over
prepubertal ages P15–P25 with either EB (0.05 g every day) or sesame
oil; additional females were not injected during this period. At 6 weeks of
age, all female subjects in both cohorts were ovariectomized and im-
planted with an E2 capsule (details above). All behavioral testing began
when subjects were 9 weeks of age. Since we never observed any statisti-
cally significant differences in aspects of behavior between the experi-
mental groups in either cohort that were given oil vehicle injections
versus no injections, we combined the data for the oil-treated and non-
treated subjects into a single “control” group within the WT and ArKO
females used for each experiment.
Behavioral analyses
All tests of behavior were performed beginning 6 h after the onset of the
dark phase of the light/dark cycle (reversed 12 h light/dark cycle, lights off
at 8:00 A.M.).
Lordosis behavior.Weekly lordosis tests were conducted in a Plexiglas
aquarium (35 cm long 25 cm high 19 cm wide). A sexually experi-
encedmale was placed alone in the aquarium and allowed to adapt for 15
min. Subsequently, 3 h after receiving a P4 injection (500g), the lordosis
responses of the female to the mounts of the stimulus male were re-
corded. The test lasted until the female received 20mounts or 15min had
elapsed. A lordosis quotient (LQ) was calculated by dividing the number
of lordosis responses displayed by the female subjects by the number of
mounts received (100).
Mate preference test. To assess mate preferences shown in response to
auditory and/or olfactory stimuli, we used a box (60 13 30 cm) that
was divided into three compartments using perforated opaque parti-
tions. An intact male stimulus and an estrous female stimulus were
placed in the lateral compartments with their own bedding to make the
stimuli as odorous as possible. Three hours after receiving a P4 injection
(500 g), the female subject was introduced into the middle compart-
ment, and was observed for 10 min. The time the subject spent poking
her nose through the holes of the partition or actively sniffing the bottom
of the partition in front of the female versus male stimulus animal was
recorded.
Mounting behavior. After completing the above tests, we replaced the
E2 capsule by one (same dimensions) containing T. Twoweeks later, tests
were conducted in a Plexiglas aquarium. A female subject was placed
alone in the aquarium and allowed to adapt for 15min. Subsequently, an
estrous stimulus female was introduced and the number of mounts in-
cluding pelvic thrusting movements shown by the female subject was
scored for 30 min.
Experiment 1: EB treatment from P5 to P15
Groups were first tested for lordosis behavior. Aminimumof four tests is
normally required to observe significant levels of lordosis behavior
(LQ  50) in WT females (Bakker et al., 2002; Kudwa and Rissman,
2003). However, we stopped after three lordosis tests since none of the
females given early postnatal EB showed any lordosis behavior, and ac-
tually showed increased aggressive behavior toward the stimulus males,
whereasWT controls already showed substantial levels of lordosis behav-
ior (LQ 50). We also did not assess mate preferences in this cohort of
animals because no restoration in lordosis behavior was observed in
EB-treated ArKO animals. Next, each group received a T implant and
was tested once for mounting behavior with an estrous female.
Experiment 2: EB treatment from P15 to P25
Groups were first tested for lordosis behavior. Since we observed that
lordosis behavior continued to increase in the fourth test in EB-treated
ArKO females, we conducted a total of six lordosis tests over a 6-week
period. Next, mate preferences were determined once following treat-
ment with E2 and P4. Then, all subjects received a T implant and were
subsequently tested once for mounting behavior 2 weeks later.
Statistical analysis
All behavioral data were analyzed using repeatedmeasures ANOVA (Sta-
tistica 8.0) using genotype (2) and early postnatal or prepubertal treat-
ment (2) as independent variables and tests as the repeated measure.
When appropriate, all ANOVAs were followed by Fisher’s least signifi-
cant difference post hoc comparisons adapted for repeated-measures
ANOVA.Only significant ( p 0.05) effects detected by theANOVAs are
presented here. To analyze mounting behaviors or results of single lor-
dosis test sessions, we performed a two-way ANOVA [genotype (2) 
treatment (2)].
Results
Experiment 1: EB treatment from P5 to P15
Lordosis behavior
As found by Bakker et al. (2002), ArKO control females showed
significantly less lordosis than WT control females. This deficit
was not rescued in ArKO females by early postnatal P5–P15 EB
treatment. Indeed, treatment of WT females with EB over this
period defeminized their lordosis behavior (Fig. 1A). ANOVA
showed a significant interaction between genotype and treatment
in test 3 (F(1,34) 5.34, p 0.03). Post hoc analyses indicated that
lordosis quotients were lower in ArKO control females and in
WT and ArKO females treated with EB compared with WT con-
trol females.
Mounting behavior
As found by Bakker et al. (2002), ArKO control females showed
significantly less mounting than WT control females. EB treat-
ment between P5 and P15 strongly increased mounting behavior
in both ArKO and WT females following adult treatment with T
(Fig. 2A). ANOVA showed a significant effect of treatment
(F(1,27) 59.8, p 0.001) indicating that all females treated with
EB during the early postnatal period displayed more mounts in
adulthood. When we only compared control groups, ANOVA
revealed a significant effect of genotype (F(1,22)  11.65, p 
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0.002) indicating that WT control females showed more mount-
ing behavior than ArKO control females.
Experiment 2: EB treatment from P15 to P25
Lordosis behavior
EB treatment from P15 to P25 almost completely rescued the
later ability of ArKO females to display lordosis behavior,
whereas EB given over this prepubertal period had no defeminiz-
ing effects on lordosis behavior in WT females (Figure 1B).
Repeated-measures ANOVA on lordosis quotients over the six
consecutive tests showed a significant interaction among test,
genotype and treatment (F(5,205)  4.01, p  0.002). Post hoc
analyses of data from tests 5 and 6 indicated that lordosis quo-
tientswere significantly lower inArKOcontrol females compared
with the three other groups, whereas lordosis quotients were
equivalent among EB-treated ArKO females, WT control fe-
males, and EB-treatedWT females. Significant increments in lor-
dosis quotients occurred, to differing degrees, with repeated
testing in all 4 groups. Thus, post hoc analyses indicated that
lordosis quotients increased significantly from test 1 to test 4
before reaching plateau values in tests 5 and 6 inWT control and
EB-treated WT females, whereas they increased significantly
from test 3 to test 5 in EB-treatedArKO females and from test 1 to
test 5 in ArKO controls.
Mate preference test
EB-treated ArKO female mice, like WT control and EB-treated
WT females, showed a strong preference for an intact male over
an estrous female, whereas ArKO control females showed no
clear preference to approachmale versus female stimulus animals
(Fig. 3). This was confirmed by ANOVA on the time spent inves-
tigating themale versus female compartment. A significant inter-
action among stimulus, genotype and prepubertal treatment
(F(1,40)  8.19, p  0.007) was obtained. Post hoc analyses indi-
cated that WT control and EB-treated WT and ArKO females
spent more time investigating the compartment containing the
intact male versus the estrous female, whereas ArKO control fe-
males spent equal time investigating the two compartments.
Mounting behavior
Again, ArKO control females showed significantly less mounting
behavior than WT control females following adult treatment
Figure 1. Effect of early postnatal (A; P5–P15) or prepubertal (B; P15–P25) EB treatment of
WT and ArKO female mice on the expression of lordosis behavior in adulthood following ovari-
ectomy and treatment with ovarian hormones. Mean SEM lordosis quotients over consecu-
tive tests in WT control females, WT females treated with EB, ArKO control females, and ArKO
females treatedwith EB are shown.A, Values forWT control females on test 3were significantly
higher than values for the other 3 groups of femalemice (*p0.05) bypost hoc tests.B, Values
for the ArKO control females on tests 5 and 6 were significantly lower than values for the other
3 groups of femalemice (*p0.05) bypost hoc tests. The number of femalemice in eachgroup
is given in parentheses.
Figure 2. Effect of early postnatal (A; P5–P15) or prepubertal (B; P15–P25) EB treatment of
WT and ArKO female mice on the later display of female-directed mounting behavior in adult-
hood following ovariectomy and treatment with testosterone. Mean  SEM numbers of
mounts displayed by WT control females, WT females treated with EB, ArKO control females,
and ArKO females treated with EB are shown. Means with different superscript letters are
significantly different from each other by post hoc comparisons ( p 0.05). The number of
female mice in each group is given in parentheses.
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with T. This deficit was also seen in EB-treated ArKO females,
showing that prepubertal EB treatment did not rescue this behav-
ior. Prepubertal treatment with EB also did not affect later
mounting behavior in WT females (Fig. 2B). ANOVA showed a
significant genotype effect (F(1,43) 26.15, p 0.001) indicating
that WT female groups showed higher levels of mounting when
paired with an estrous female than ArKO female groups, regard-
less of the prepubertal hormonal treatment received.
Discussion
An important organizational role for E2 in male-typical differen-
tiation of rodent sexual behavior is widely accepted and indeed,
was confirmed in the present experiments. However, until now it
has not been clear whether E2 contributes to the female-typical
development of sexual behaviors. The present study provides
new evidence for such an active role of prepubertal E2 in female-
typical differentiation of brain mechanisms controlling both ap-
petitive and consummatory aspects of female sexual behavior.
Thus the ability of ArKO female mice to show WT-like levels of
lordosis behavior in response to adult ovarian hormones was
almost completely rescued by daily treatment with EB over a
specific prepubertal period, P15–P25, whereas EB given over an
earlier postnatal period (P5–P15) had no such effect in ArKO
females and actually abolished lordosis behavior in WT females.
In addition, prepubertal EB treatment restored themotivation of
ArKO females to prefer to approach distal cues from a stimulus
male as opposed to another female. These findings suggest that
the classic view of a default organization of female typical neural
and behavioral characteristics must be revised. Evidence from a
previous retrospective interview study (Downey et al., 1989) of
Turner syndrome (45, XO) women in whom the ovaries failed to
develop are also consistent with, though not definitive proof of,
an active role of E2 in the development of female sexual behavior.
The Turner sample, who (29 of 31 subjects) received exogenous
ovarian hormones as young adults, was significantly less likely
than a control group of ovary intact (46, XX) women with con-
stitutional short stature to have ever had a boyfriend or to have
engaged in sexual activity with a man. Even though the Turner
syndrome and control subjects were matched for short stature,
there were additional cognitive and/or physical attributes of
Turner Syndrome women (in addition to the absence of ovarian
E2) that could have contributed to observed group differences in
psychosexual function. Further studies are needed in women and
in other mammalian species to test the generality of our conclu-
sion that prepubertal E2 is normally required for the development
of female sexual behavior.
The classic view of the sexual differentiation of brain and behav-
ior inmale rodents holds that perinatal T exerts strong defeminizing
effects on the neural mechanisms mediating sexual behavior, with
these effects of T being mediated by E2 derived from local aromati-
zation of T. The present results confirm the defeminizing effects of
neonatal E2 on the brain since lordosis behavior was completely
suppressed inWT females given EB between P5 and P15. They also
corroborate an early study showing that neonatal T and E2 were
equally effective in suppressing sexual receptivity in female mice
(Edwards and Thompson, 1970), and are in line with many addi-
tional studies conducted in additional rodent species (for review, see
Wallen and Baum, 2002).
The classic view of brain sexual differentiation also holds that
female-typical brain and behavior develop in the absence of any
active hormone signaling. This conclusion was primarily based
on the finding that male rodents neonatally deprived of T or E2
showed lordosis behavior when primed with E2 and P4 in adult-
hood (for review, see Baum, 1979). Along with the seminal work
of Toran-Allerand (1976), the possible importance of E2 in
female-typical differentiation of sexual behaviorwas suggested by
early behavioral studies (Lisk, 1969; Gerall et al., 1973) showing
that female rats ovariectomized on the day of birth had lower
lordosis quotients following adult treatment with E2 and P4 than
females that either kept their ovaries (Lisk, 1969) or were im-
planted with ovaries from birth until postnatal day 60 (Gerall et
al., 1973). These various behavioral results thus suggested that
exposure to E2 over a postnatal interval between birth and the age
of puberty facilitated the later capacity to display female sexual
behavior; however, they did not provide incontrovertible evi-
dence that E2 normally contributes to the development of female
sexual behavior in female mammals. For instance, the effects of
neonatal ovariectomy on the potential to show lordosis behavior
later in life were only transient (Gerall et al., 1973). However, our
observation (Bakker et al., 2002) of reduced lordosis behavior
and lack of amale-directedmate preference in female ArKOmice
resurrected the question of whether E2 actively contributes to the
development of the female brain. The present results identify a
specific prepubertal period during which E2 exerts a feminizing
action on both appetitive and consummatory aspects of female
sexual behavior inmice. Finally, prepubertal (P15–P25) EB treat-
ment had no detrimental effect on the expression of lordosis behav-
ior byWT females, whereas earlier neonatal (P5–P15) EB treatment
strongly defeminizedWT females. These results suggest that the de-
feminization of sexual behavior capacity that normally occurs in
male mice is completed by the actions of E2 before P15.
Our finding in both experiments that WT control females
showedmore mounting behavior (after T treatment) than ArKO
control females provide an endocrine explanation for why female
mice normally show male-typical mating behavior and argue
against a previous proposal (Kimchi et al., 2007) that femalemice
will only display male-like mounting behavior when adult func-
tion of vomeronasal sensory neurons is disrupted. Our observation
that early postnatal (P5–P15) EB treatment strongly masculin-
ized both WT and ArKO females confirms the classic view that
neonatal E2, formed via the neural aromatization of circulating T,
Figure 3. Effect of prepubertal (P15–P25) EB treatment of WT and ArKO females on mate
preference in adulthood following ovariectomy and treatment with ovarian hormones. Shown
aremean SEMtimes spent byWT control females,WT females treatedprepubertallywith EB,
ArKO control females, and ArKO females treated prepubertally with EB investigating the com-
partment containing an intactmale versus an estrous female. *p 0.05, post hoc comparisons
of time spent investigating the two types of stimulus animals. The number of female mice in
each group is given in parentheses.
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masculinizes aspects of brain and behavior in male mice. The
neural substrate that controls mounting behavior in adulthood
could normally be masculinized in fetal females by the local aro-
matization of T derived either from fetal males lying adjacent to
the developing female fetuses (vom Saal and Bronson, 1980) or
from the placenta which could also be a significant source of T, as
was observed in fetal rats (Gibori and Sridaran, 1981; Vreeburg et
al., 1983; Baum et al., 1991). In contrast with lordosis capacity
and male-oriented mate preferences, prepubertal (P15–P25) EB
treatment did not rescuemounting capacity in ArKO females nor
did it masculinize this behavior in WT females. These results
suggest that by P15 the critical period for the development of the
mounting behavior neural substrate is completed; they also pro-
vide further evidence that the neural substrate for female- and
male-typical sexual behaviors in mice have different responses to
E2 across the first 4 weeks of life (for review, see Baum, 1979). The
neural substrate for female-typical sexual behavior is defeminizedby
early postnatal E2 actions (P5–P15) and actively feminized by the
same sex hormone acting prepubertally over P15–P25. By con-
trast, E2 acts solely over the early postnatal period (P0–P15) to
masculinize the substrate for male sex behavior. After P15, this
male behavior substrate is impervious to E2 manipulation until
adulthood, when this hormone, perhaps acting with T, activates
this behavior. Indeed, the high level of mounting shown in EB-
treated ArKO females (P5–P15) confirms the ability of adult T to
activate this behavior, even in the absence of its conversion to E2.
It should be noted that, in male mice, organization of mounting
behavior capacity is mediated, at least in part, by an androgen
receptor-mediated process (Raskin et al., 2009). To date, no data
are available on the effects of knocking out the androgen receptor
on the adult expression of mounting behavior by female mice so
it is unknown whether different hormonal mechanisms underlie
the organization of the neural circuitry regulating mounting be-
havior in the 2 sexes.
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